Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease

Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease

Beyer JE

Journal Of Pain And Symptom Management

2000

Child; Female; Humans; Male; Analgesics; Anemia; adolescent; P.H.S.; Research Support; U.S. Gov't; Interviews; Pain/physiopathology; Opioid/therapeutic use; Analgesia/standards; Nalbuphine/therapeutic use; Sickle Cell/complications; Vascular Diseases/etiology/physiopathology/therapy

The effectiveness of analgesia during sickle cell crisis was examined in this descriptive, exploratory study. Pain scores (using the African-American Oucher and the Adolescent Pediatric Pain Tool) and analgesics administered were examined during a 2-hour observation/interview in the hospital while children/adolescents with sickle cell disease (SCD) experienced a vaso-occlusive episode (VOE). A convenience sample of twenty-one 6- to 16-year olds with SCD was included. Evidence indicated that 15 of the 21 children in the sample were in moderate to severe pain during their interviews, indicating that the analgesics did not effectively control their pain. Most participants (17) had received nalbuphine as the primary analgesic by intravenous infusion drip and/or patient-controlled analgesia pump. Many reasons were identified for the inadequate analgesia. The results suggested that the pain of SCD is very complex, requiring continuous adjustment of comfort measures, especially analgesics. More research is needed to examine pain control in children with SCD.

2000

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog